首頁 > 市場調查報告書 > 醫療設備

組織和器官移植市場規模、佔有率和成長分析：按移植類型、捐贈者類型、最終用戶、服務和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2091232

組織和器官移植市場規模、佔有率和成長分析：按移植類型、捐贈者類型、最終用戶、服務和地區分類－2026-2033年產業預測

Tissue And Organ Transplantation Market Size, Share, and Growth Analysis, By Transplant Type (Kidney Transplantation, Liver Transplantation), By Donor Type (Deceased Donor, Living Donor), By End-User, By Service, By Region - Industry Forecast 2026-2033

出版日期: 2026年07月09日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球組織和器官移植市場價值為 85.2 億美元，預計到 2025 年將成長至 90.6 億美元，到 2033 年將成長至 148.5 億美元，在預測期（2026-2033 年）內複合年成長率為 6.3%。

市場分析表明，全球組織和器官移植市場主要由人體組織和器官的獲取、加工和分發所驅動，這些組織和器官對於應對嚴重的器官衰竭和大量組織缺損至關重要。該市場對於挽救生命、提高生活品質和降低醫療成本至關重要。從基礎的配型系統到先進的生物銀行和分發網路，該領域已取得顯著進展。隨著慢性病的增加，需求激增；而由於免疫抑制療法的廣泛應用，捐贈者數量也在增加。協調各地區的法規對於簡化物流和提高捐贈者參與度至關重要。統一的倫理指南使製造商能夠有效率地擴展生物樣本庫，從而為新興企業創造商機。這些效率的提升正在提高移植器官的可用性，並促使保險公司採取支持性的報銷策略。

全球組織和器官移植市場的成長要素

全球組織和器官移植市場正受到免疫抑制療法進步的顯著推動。這些療法提高了治療的精準度，從而降低了器官排斥的風險並最大限度地減少了副作用。這項進步賦予了臨床醫生更大的自主權，最終擴大了合格移植條件的患者群體，並促使醫院加強其移植計畫。隨著生存率的持續提高，對組織和器官移植服務的需求也不斷成長。這種不斷成長的需求推動了對醫療基礎設施和研究舉措的投資增加，並加強了學術機構和私營部門之間的合作，以改善移植效果。

全球組織和器官移植市場的限制因素

全球組織和器官移植市場面臨嚴峻挑戰，主要源自於有關知情同意、器官分配和捐贈者資訊透明度的嚴格監管。這些監管規定因地區而異，給醫療機構帶來了沉重的行政負擔，要求每次移植手術都需提交詳細的文件、經歷漫長的核准流程並接受強制性合規性審計。因此，這種複雜性可能導致治療啟動延遲和運作成本增加，一些醫療機構甚至不得不限制或推遲移植手術。這種限制最終阻礙了市場成長，抑制了相關服務和技術的快速發展，並阻礙了移植效果的改善和創新。

全球組織與器官移植市場趨勢

全球組織和器官移植市場正經歷著向精準基因組匹配的重大轉變，徹底革新了供體-受體相容性評估。這種前沿方法利用高解析度基因測序來識別分子層面的相容性，使臨床醫生能夠制定個人化的免疫抑制治療方案，降低排斥反應率，並延長移植器官的存活時間。這種以患者為中心的策略不僅加快了移植前評估並最佳化了匹配流程，還促進了醫療機構間基因組數據的共用，從而推動了合作研究舉措的開展。因此，可移植器官的供應量增加和患者預後的改善正在推動市場成長，並重塑全球移植模式。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Terumo BCT
Paragonix Technologies
TransMedics Group
XVIVO Perfusion AB
Bridge to Life
Organ Recovery Systems
LifeNet Health
AlloSource
BioLife Solutions
RTI Surgical
Musculoskeletal Transplant Foundation（MTF）
Community Tissue Services
Lions Eye Bank
Saving Sight
Eye Bank Association of America
UNOS（United Network for Organ Sharing）
Mayo Clinic Transplant Center
Cleveland Clinic
Johns Hopkins Transplant
UCSF Transplant Program

結論與建議

簡介目錄

Product Code: SQMIG35D2584

Global Tissue And Organ Transplantation Market size was valued at USD 8.52 Billion in 2024 and is poised to grow from USD 9.06 Billion in 2025 to USD 14.85 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

Market insights indicate that the global tissue and organ transplantation landscape is driven by the procurement, processing, and distribution of human tissues and organs, vital for addressing severe organ failure and significant tissue loss. The market is essential for saving lives, enhancing quality of life, and lowering healthcare expenses. Significant advancements have evolved from basic matching systems to sophisticated biobanking and allocation networks. Demand has surged due to rising chronic diseases, while immunosuppressive therapies have expanded donor pools. Regulatory harmonization across regions is crucial, as it simplifies logistics and boosts donor engagement. Unified ethical guidelines enable manufacturers to enhance biobanks efficiently, creating opportunities for emerging players. This increased efficiency has led to improved graft availability and encourages insurers to adopt supportive reimbursement strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue And Organ Transplantation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue And Organ Transplantation Market Segments Analysis

Global tissue and organ transplantation market is segmented by transplant type, donor type, end-user, service and region. Based on transplant type, the market is segmented into kidney transplantation, liver transplantation, heart transplantation, lung transplantation and tissue (cornea, bone, skin). Based on donor type, the market is segmented into deceased donor and living donor. Based on end-user, the market is segmented into transplant centers, hospitals and organ procurement organizations (OPOs). Based on service, the market is segmented into transplant surgery, post-transplant care and organ preservation. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue And Organ Transplantation Market

The Global Tissue and Organ Transplantation market is significantly driven by advancements in immunosuppressive therapies that enhance the accuracy of treatments, thereby lowering the risk of organ rejection and minimizing side effects. This improvement instills confidence in clinicians, ultimately widening the pool of eligible recipients and prompting hospitals to bolster their transplantation programs. As survival rates continue to rise, there is an escalating demand for tissue and organ transplantation services. This heightened demand catalyzes greater investments in healthcare infrastructure and research initiatives, fostering stronger collaborations between academic institutions and the private sector to improve transplantation outcomes.

Restraints in the Global Tissue And Organ Transplantation Market

The Global Tissue and Organ Transplantation market faces significant challenges due to stringent regulations surrounding consent, organ allocation, and donor transparency, which vary across different regions. These regulations necessitate detailed documentation, prolonged approval processes, and obligatory compliance audits for each transplantation, imposing a heavy administrative burden on healthcare facilities. Consequently, these complexities can delay treatment initiation and increase operational expenses, leading some institutions to limit or postpone transplant procedures. This restraint ultimately hampers market growth and inhibits the swift advancement of associated services and technologies within the sector, creating barriers to improving transplant outcomes and fostering innovation.

Market Trends of the Global Tissue And Organ Transplantation Market

The Global Tissue and Organ Transplantation market is witnessing a significant shift towards precision genomic matching, revolutionizing donor-recipient compatibility assessments. This cutting-edge approach leverages high-resolution genomic sequencing to identify molecular-level compatibilities, allowing clinicians to customize immunosuppressive therapies to mitigate rejection rates and enhance graft longevity. This patient-centric strategy not only expedites pre-transplant evaluations and optimizes matching processes but also promotes collaborative research initiatives that facilitate genomic data sharing among institutions. Consequently, the widening availability of viable transplants and improved patient outcomes are driving market growth and reshaping the landscape of transplantation globally.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Tissue And Organ Transplantation Market Size by Transplant Type & CAGR (2026-2033)

Market Overview
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Tissue (Cornea)
Bone
Skin

Global Tissue And Organ Transplantation Market Size by Donor Type & CAGR (2026-2033)

Market Overview
Deceased Donor
Living Donor

Global Tissue And Organ Transplantation Market Size by End-User & CAGR (2026-2033)

Market Overview
Transplant Centers
Hospitals
Organ Procurement Organizations (OPOs)

Global Tissue And Organ Transplantation Market Size by Service & CAGR (2026-2033)

Market Overview
Transplant Surgery
Post-Transplant Care
Organ Preservation

Global Tissue And Organ Transplantation Market Size & CAGR (2026-2033)

North America (Transplant Type, Donor Type, End-User, Service)
- US
- Canada
Europe (Transplant Type, Donor Type, End-User, Service)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Transplant Type, Donor Type, End-User, Service)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Transplant Type, Donor Type, End-User, Service)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Transplant Type, Donor Type, End-User, Service)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Terumo BCT
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paragonix Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TransMedics Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
XVIVO Perfusion AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bridge to Life
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organ Recovery Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeNet Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AlloSource
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RTI Surgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Musculoskeletal Transplant Foundation (MTF)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Community Tissue Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lions Eye Bank
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Saving Sight
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eye Bank Association of America
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
UNOS (United Network for Organ Sharing)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mayo Clinic Transplant Center
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cleveland Clinic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johns Hopkins Transplant
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
UCSF Transplant Program
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments